Cerebral Angiography Market, By Imaging Technique, By Application, By Patient Age, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Cerebral Angiography Market size was valued at US$ 1,358.91 Million in 2025, expanding at a CAGR of 6.70% from 2026 to 2033.

Cerebral angiography is a diagnostic imaging technique in which a contrast agent is introduced into the arterial system and X ray images are acquired to visualize the blood vessels of the brain, enabling clinicians to detect vascular abnormalities such as aneurysms, arteriovenous malformations, and occlusions with high resolution and precision. Its application extends to a detailed assessment of cerebral vasculature and is often integrated into treatment planning and endovascular interventions. At the public health level, authoritative government and global health data indicate that cerebrovascular diseases, particularly stroke, constitute a substantial health burden and a key driver of demand for advanced neurovascular imaging; stroke is recognized by the World Health Organization as one of the leading causes of death and disability globally, demonstrating persistent incidence and prevalence that reinforce the central role of accurate vascular imaging in health systems and clinical pathways.

Cerebral Angiography Market- Market Dynamics

Increasing Global Burden of Stroke and Cerebrovascular Diseases

The rising prevalence of stroke and other cerebrovascular conditions is a major factor supporting the demand for cerebral angiography procedures. Cerebral angiography is widely used to visualize blood vessels in the brain and diagnose abnormalities such as aneurysms, vascular malformations, and arterial blockages that can lead to stroke. As the number of stroke cases increases globally, healthcare systems require more advanced imaging procedures to support accurate diagnosis and treatment planning. Government and public health statistics indicate a significant global burden of stroke. According to the World Health Organization (WHO), millions of new stroke cases occurred worldwide, and about millions of people were living with stroke globally. The organization also reports that one in four adults is expected to experience a stroke during their lifetime, highlighting the growing need for diagnostic imaging in neurological care. Because cerebral angiography provides detailed images of cerebral blood vessels, hospitals and neurovascular centers increasingly use it for confirming vascular abnormalities and planning interventional procedures. As the incidence of stroke and related vascular disorders continues to be reported in national health statistics, the need for accurate neurovascular imaging technologies is likely to support the adoption of cerebral angiography systems in healthcare facilities.

Cerebral Angiography Market- Segmentation Analysis:

The Global Cerebral Angiography Market is segmented on the basis of Imaging Technique, Application, Patient Age, Indication, End User, and Region.

The market framework identifies four segments based on imaging technique: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), and Catheter Angiography. Digital Subtraction Angiography (DSA) continues to represent a key segment in the cerebral angiography market due to its ability to provide highly detailed, real-time images of brain blood vessels, making it particularly useful for identifying aneurysms, arteriovenous malformations, and vascular narrowing. While non-invasive techniques such as Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) are gaining popularity, DSA remains essential for complex cases and surgical planning. Public health guidance supports its use: the American Heart Association reports approximately lakhs of strokes in the U.S. each year, emphasizing the need for precise vascular imaging, and the UK's National Health Service recommends DSA for cases requiring accurate vascular mapping during interventions. These factors collectively underscore DSA's continued prominence in clinical practice.

The market framework identifies three segments based on application: Neurology, Neurosurgery, and Interventional Radiology. The Neurology segment emerges as a significant segment in the cerebral angiography market, as it is widely used to diagnose and monitor cerebrovascular conditions such as stroke, aneurysms, and arteriovenous malformations. Cerebral angiography provides neurologists with detailed images of brain blood vessels, supporting timely diagnosis and effective management of neurovascular disorders, with early detection of abnormalities being key to preventing complications. Public health data underscores this need: the Centre for Disease Control and Prevention (CDC) reports that people in the U.S. experience a stroke each year, including approximately lakhs of first-time cases, while the World Health Organization (WHO) notes that cerebrovascular diseases cause over millions of deaths globally. These figures highlight the importance of neurological imaging in both clinical care and public health planning, reinforcing neurology as the primary application driving demand for cerebral angiography.

Cerebral Angiography Market- Geographical Insights

In the global cerebral angiography market, North America and Asia Pacific are notable leaders due to differences in healthcare infrastructure, disease prevalence, and technology adoption. North America holds the largest share, around 41.8 %, driven by advanced healthcare systems, widespread availability of neuroimaging technologies, and significant investment in diagnostic and interventional care for cerebrovascular diseases; the high incidence of stroke in the U.S. and Canada, combined with the extensive use of CT and MRI scanners, sustains demand for detailed vascular imaging. Asia Pacific, while smaller in current share, is experiencing rapid growth due to expanding healthcare infrastructure in countries like China and India, increasing awareness of stroke and neurovascular conditions, and government initiatives to improve access to advanced diagnostics, supported by large populations and a rising number of stroke cases. These trends highlight how healthcare capacity, disease burden, and public sector support influence the adoption and expansion of cerebral angiography across regions.

Cerebral Angiography Market- Country Insights

Worldwide, the United States maintains a strong presence in the cerebral angiography market, driven by the adoption of sophisticated neuroimaging tools and the need for detailed vascular diagnosis. The country faces a considerable burden of stroke and other cerebrovascular conditions; the Centre for Disease Control and Prevention (CDC) reports that over lakhs of people in the U.S. experience a stroke each year, including approximately lakhs of first-time strokes, with about 87 % being ischemic strokes that require precise imaging for effective treatment. These figures highlight the demand for cerebral angiography, which offers detailed visualization of brain blood vessels to detect abnormalities and assist in clinical decision-making. The combination of high disease prevalence, robust healthcare infrastructure, and access to advanced imaging systems reinforces the United States leading position in the global market.

Cerebral Angiography Market- Competitive Landscape:

In the competitive landscape of the cerebral angiography market, a number of established medical imaging and device companies offer advanced angiography systems, software, and supporting technologies for detailed visualization of cerebral blood vessels and efficient clinical workflows. Leading global players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems are known for their comprehensive cerebral angiography solutions and continuous improvements in imaging quality and clinical support. Other important contributors, including Shimadzu Corporation, Boston Scientific Corporation, AngioDynamics, and Medtronic, add variety to the market with specialized products designed for diverse healthcare environments. These companies sustain their market presence through ongoing research and development, wide distribution channels, and product updates that address clinical demands, particularly for diagnosing and managing neurovascular diseases like stroke, which remains a priority for public health authorities and national healthcare planning.

Recent Developments:

In December 2025, Stratasys announced full commercial availability of its RadioMatrix radiopaque 3D printing material across the U.S., enabling healthcare providers and researchers to create patient-specific models with tunable X-ray visibility for imaging and training. This development is expected to enhance medical education, improve procedural planning, and support more accurate simulations, ultimately contributing to better patient outcomes and advancing innovation in medical imaging technologies.

In February 2025, the FDA granted 510(k) clearance to RapidAI's Lumina 3D software, which delivers AI-powered 3D CTA reconstructions of head and neck scans within minutes, improving visualization and accelerating neuroradiology workflow. This advancement is set to streamline diagnostic processes, enhance clinical decision-making, and support faster, more precise patient care in neuroradiology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare
Siemens Healthineers
Koninklijke Philips N.V.
Shimadzu Corp.
Canon Medical Systems Corporation
Samsung Medison
St. Jude Medical, Inc.
Hitachi Medical Corporation
TERUMO Corporation
Medtronic plc
Stryker Corporation
AngioDynamic, Inc.
Penumbra, Inc.
MicroPort Scientific Corporation
Cordis
Cook Medical LLC

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033

Digital Subtraction Angiography (DSA)
Magnetic Resonance Angiography (MRA)
Computed Tomography Angiography (CTA)
Catheter Angiography
Intraoperative Angiography

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Neurology
Neurosurgery
Interventional Radiology
Others

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033

Adult Patients
Pediatric Patients

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

Stroke
Aneurysm
Arteriovenous Malformation (AVM)
Carotid Artery Disease
Brain Tumors

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Hospitals
Diagnostic Imaging Centers
Specialty Neurology Clinics
Research Institution
Ambulatory Surgical Centers

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV6196

1. Cerebral Angiography Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cerebral Angiography Market Snippet by Imaging Technique
- 2.1.2. Cerebral Angiography Market Snippet by Application
- 2.1.3. Cerebral Angiography Market Snippet by Patient Age
- 2.1.4. Cerebral Angiography Market Snippet by Indication
- 2.1.5. Cerebral Angiography Market Snippet by End User
- 2.1.6. Cerebral Angiography Market Snippet by Country
- 2.1.7. Cerebral Angiography Market Snippet by Region
2.2. Competitive Insights

3. Cerebral Angiography Key Market Trends

3.1. Cerebral Angiography Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cerebral Angiography Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cerebral Angiography Market Opportunities
3.4. Cerebral Angiography Market Future Trends

4. Cerebral Angiography Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cerebral Angiography Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Cerebral Angiography Market Landscape

6.1. Cerebral Angiography Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cerebral Angiography Market - By Imaging Technique

7.1. Overview
- 7.1.1. Segment Share Analysis, By Imaging Technique, 2025 & 2033 (%)
- 7.1.2. Digital Subtraction Angiography (DSA)
- 7.1.3. Magnetic Resonance Angiography (MRA)
- 7.1.4. Computed Tomography Angiography (CTA)
- 7.1.5. Catheter Angiography
- 7.1.6. Intraoperative Angiography

8. Cerebral Angiography Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Neurology
- 8.1.3. Neurosurgery
- 8.1.4. Interventional Radiology
- 8.1.5. Others

9. Cerebral Angiography Market - By Patient Age

9.1. Overview
- 9.1.1. Segment Share Analysis, By Patient Age, 2025 & 2033 (%)
- 9.1.2. Adult Patients
- 9.1.3. Pediatric Patients

10. Cerebral Angiography Market - By Indication

10.1. Overview
- 10.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
- 10.1.2. Stroke
- 10.1.3. Aneurysm
- 10.1.4. Arteriovenous Malformation (AVM)
- 10.1.5. Carotid Artery Disease
- 10.1.6. Brain Tumors

11. Cerebral Angiography Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Diagnostic Imaging Centers
- 11.1.4. Specialty Neurology Clinics
- 11.1.5. Research Institution
- 11.1.6. Ambulatory Surgical Centers

12. Cerebral Angiography Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Cerebral Angiography Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Cerebral Angiography Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Cerebral Angiography Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Cerebral Angiography Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Cerebral Angiography Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Cerebral Angiography Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
13.3. GE Healthcare
13.4. Siemens Healthineers
13.5. Koninklijke Philips N.V.
13.6. Shimadzu Corp.
13.7. Canon Medical Systems Corporation
13.8. Samsung Medison
13.9. St. Jude Medical, Inc.
13.10. Hitachi Medical Corporation
13.11. TERUMO Corporation
13.12. Medtronic plc
13.13. Stryker Corporation
13.14. AngioDynamic, Inc.
13.15. Penumbra, Inc.
13.16. MicroPort Scientific Corporation
13.17. Cordis
13.18. Cook Medical LLC

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us